A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-Negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
- Clinicaltrials.gov #: NCT03701334
- Acronym: NATALEE
- Tumor Type: Breast
- Tumor Subtype: ER +ve
- Tumor Stage: N/A
- Type of Treatment:
| Institution(s): | PI: | CRC: | |
|---|
| Odette Cancer Centre | Ellen Warner | Tammy Taite | Email PI & CRC |
| Southlake Regional Health Centre | Yasmin Rahim | Shany Loukiantchenko | Email PI & CRC |
